Achillion Pharmaceuticals (ACHN)
|
9.12
-0.08 (-0.87%)
|
|
|
|
ACHN analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ACHN price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
ACHN earnings
Date
Actual
Expected
Prev Yr Qtr
11/8/2012
-0.20
-0.17
-0.15
8/8/2012
-0.16
-0.17
-0.19
5/9/2012
-0.13
-0.15
-0.17
Achillion Pharmaceuticals (ACHN) Upgrades
Date
Analyst
Old Rating
New Rating
02/02/2010
Wedbush
Neutral
Outperform
08/07/2009
JMP Securities
Underperform
Market Perform
Achillion Pharmaceuticals (ACHN) Downgrades
Date
Analyst
Old Rating
New Rating
10/30/2008
Oppenheimer
Outperform
Perform
Achillion Pharmaceuticals (ACHN) New Coverage
Date
Analyst
Rating
09/19/2012
Deutsche Bank
Buy Calls Under- Appreciated
06/13/2012
Maxim Group
Buy
12/23/2009
Roth
Buy
10/28/2009
National Securities
Buy
04/14/2009
Merriman Curhan
Buy
01/27/2009
ThinkPanmure
Buy
